Clinical Efficacy of 10% Arginine Bicarbonate Prophylaxis Paste
Launched by COLGATE PALMOLIVE · Feb 9, 2010
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female subjects, ages 18-70, inclusive.
- • Availability for the three (3) week duration of the study.
- • Two (2) sensitive teeth, which must be anterior to the molars, and demonstrate cervical erosion/abrasion or gingival recession.
- • Qualifying response to tactile stimuli (Yeaple probe) as defined by a score between 10-50gms. of force.
- • Qualifying response to the air blast stimuli as defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale.
- • Subjects need to satisfy the qualifying response to stimuli for both the parameters assessed (tactile or air) on two teeth to be entered into the study.
- • Good general health with no known allergies to products being tested.
- • Use of a non-desensitizing dentifrice for three months prior to entry into the study.
- • Signed Informed Consent Form.
- Exclusion Criteria:
- • Gross oral pathology, chronic disease, or history of allergy to test products.
- • Advanced periodontal disease or treatment for periodontal disease (including surgery) within the past twelve months.
- • Scheduled dental prophylaxis within three weeks prior to the Baseline Hypersensitivity Examination.
- • Sensitive teeth with mobility greater than one.
- • Teeth with extensive/defective restorations (including prosthetic crowns), suspected pulpitis, caries, cracked enamel, or used as abutments for removable partial dentures.
- • Subjects that began to take anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory drugs, or daily analgesics within one month prior to the start of the study or who have to start taking these during the course of the study.
- • Participation in a desensitizing dentifrice study or regular use of a desensitizing dentifrice within the past three months.
- • Current participation in any other clinical study.
- • Pregnant or lactating subjects.
- • Allergies to oral care products, personal care consumer products, or their ingredients.
- • Medical condition which prohibits not eating/drinking for 4 hours.
About Colgate Palmolive
Colgate-Palmolive is a global leader in oral care, personal care, home care, and pet nutrition, dedicated to enhancing the health and well-being of consumers worldwide. With a strong commitment to innovation and sustainability, the company conducts clinical trials to advance its product offerings, ensuring safety and efficacy while adhering to the highest ethical standards. Colgate-Palmolive's rigorous research initiatives are designed to generate scientific evidence that supports the development of effective solutions, ultimately promoting healthier lifestyles and contributing to the betterment of communities globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Langhorne, Pennsylvania, United States
Patients applied
Trial Officials
David Hamlin, DDS
Principal Investigator
Contract Dental Evaluations
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials